quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 22, 2026

ORCL Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages ORCL Investors with Losses to Contact the Firm

View original at globenewswire.com
ORCL Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages ORCL Investors with Losses to Contact the Firm RADNOR, Pa., Feb…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • OpenAI could account for more than a third of total Oracle revenues by fiscal 2028 and even a greater share by fiscal 2030

    80% confidence
  • Oracle has very good line-of-sight for capabilities to spend on CapEx right before it starts generating revenue

    80% confidence
  • Oracle now projected $50 billion of CapEx in fiscal year 2026—$15 billion more than the Company's previous projection in September 2025 and as much as $25 billion more than the Company's projection in June 2025

    80% confidence
  • OpenAI's ability to meet contractual obligations will be contingent on AI tailwinds continuing and its models being a market leader to continue to raise external financing

    80% confidence
  • Oracle's substantially increased spending on AI infrastructure would rapidly convert into accelerating revenue and profit growth

    80% confidence
  • Oracle expected to spend less than $100 billion on AI growth plans ahead

    80% confidence
  • Oracle's promises of massive new revenues from increased AI infrastructure business are unlikely to materialize

    80% confidence
  • Oracle's $248 billion lease commitment disclosure is a bombshell disclosure

    80% confidence
  • Oracle's future lease exposure far exceeds similar commitments by peers with a mismatch between long duration of property leases and much shorter contracts with key customers such as OpenAI

    80% confidence
  • This repricing in debt markets is very consistent with the view that risks are building

    80% confidence
  • Oracle really matters because it is the harbinger of the AI capex boom

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
ORCL Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages ORCL Investors with Losses to Contact the Firm — Source | Via News | pt.VIA.NEWS